The aussie market doesn't understand bulk porphyry copper, the sheer, massive value that hch is sitting on.
And CE is not the best at communicating this value proposition, he just simply lacks the ability to describe a cohesive strategy, we need a clear plan...something that brings it all together, paints a picture and inspires folks. He doesn't even provide a roadmap or a simple timeline with basic milestones and how they fit together. He's just cruising...all over the place...just like our 2020 drill plan was...a bit like a samso interview heheh.
Meanwhile, even based on very conservative discounted cashflow assumptions, this stock is worth +10c/share IMMEDIATELY, right now...eaaasy peasy. And based on current Cu price and existing MRE, it's worth 40c/share.
Soon we will be the only Tier 1, low-arsenic, copper junior with coastal property that's the envy of the world, in a Tier 1 jurisdiction, with fantastic infrastructure and lowest quartile operating cost. And the market WILL wake up. And when the re-rate happens, it will be violent and very satisfying!!
- Forums
- ASX - By Stock
- HCH
- $?Bill in a ? Life mine
$?Bill in a ? Life mine, page-4627
-
- There are more pages in this discussion • 22,721 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCH (ASX) to my watchlist
(20min delay)
|
|||||
Last
96.0¢ |
Change
0.015(1.59%) |
Mkt cap ! $145.2M |
Open | High | Low | Value | Volume |
95.5¢ | 98.5¢ | 94.5¢ | $87.27K | 91.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.5¢ | 7010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19600 | 0.940 |
2 | 10042 | 0.935 |
8 | 21572 | 0.930 |
4 | 16731 | 0.925 |
1 | 5500 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.965 | 7010 | 3 |
0.990 | 10000 | 1 |
0.995 | 35000 | 1 |
1.000 | 10371 | 2 |
1.010 | 3000 | 1 |
Last trade - 15.57pm 15/07/2024 (20 minute delay) ? |
Featured News
HCH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online